Key facts
- It has raised $7.0M; the latest was Seed Round ($7.0M) in Nov 2025.
- Notable investors include Shaanxi Financial Asset Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Mait Medical Materials
- ·The full record, as it builds
Funding rounds
No funding rounds for Mait Medical Materials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mait Medical Materials
Manufacturer of medical-use materials intended for healthcare applications. The company offers biocompatibility, durability, and specialized performance characteristics across a range of solutions, enabling hospitals, clinics, and research institutions to improve patient safety, enhance treatment effectiveness, reduce procedural risks, and support long-term reliability in demanding medical environments through consistent quality and tailored material properties.
- Sector
- Healthcare
- HQ
- Xi'an, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Mait Medical Materials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mait Medical Materials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mait Medical Materials in its N-PORT filings yet. We sweep new filings monthly.